The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Inhibition of hypoxia-inducible factor 1 activity by nitric oxide donors in hypoxia
Open accessAbstract
Nitric oxide (NO) is known to have various biologic and pathophysiologic effects on organisms. The molecular mechanisms by which NO exerts harmful effects are unknown, although various O 2 radicals and ions that result from reactivity of NO are presumed to be involved. Here we report that adaptive cellular response controlled by the transcription factor hypoxia-inducible factor 1 (HIF-1) in hypoxia is suppressed by NO. Induction of erythropoietin and glycolytic aldolase A mRNAs in hypoxically cultured Hep3B cells, a human hepatoma cell line, was completely and partially inhibited, respectively, by the addition of sodium nitroprusside (SNP), which spontaneously releases NO. A reporter plasmid carrying four hypoxia-response element sequences connected to the luciferase structural gene was constructed and transfected into Hep3B cells. Inducibly expressed luciferase activity in hypoxia was inhibited by the addition of SNP and two other structurally different NO donors, S -nitroso- l -glutathione and 3-morpholinosydnonimine, giving IC 50 values of 7.8, 211, and 490 μM, respectively. Inhibition by SNP was also observed in Neuro 2A and HeLa cells, indicating that the inhibition was not cell-type-specific. The vascular endothelial growth factor promoter activity that is controlled by HIF-1 was also inhibited by SNP (IC 50 = 6.6 μM). Induction generated by the addition of cobalt ion (this treatment mimics hypoxia) was also inhibited by SNP (IC 50 = 2.5 μM). Increased luciferase activity expressed by cotransfection of effector plasmids for HIF-1α or HIF-1α-like factor in hypoxia was also inhibited by the NO donor. We also showed that the inhibition was performed by blocking an activation step of HIF-1α to a DNA-binding form.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The Adam17 and Arg2 proteins affect Hif-1α stability and activity by regulating production of tumor necrosis factor α (TNF-α) 31,32 and nitric oxide, respectively 33,34 , whereas Mmp3 has key roles in numerous physiological processes 35 .”
From The yak genome and adaptation to life at high altitude (2012) · cites this paper as [33]
Citations
Cites
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,460
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
Green fluorescent protein as a marker for gene expression
Chalfie, M., Tu, Y., Euskirchen, G., Ward, W. W., & Prasher, D. C. (1994) · Science · doi:10.1126/science.8303295 · Cited by 6,802
The L-Arginine-Nitric Oxide Pathway
Epstein, F. H., Moncada, S., & Higgs, A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292706 · Cited by 6,678
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S. N., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,836
Schreiber, E. H., Matthias, P., Müller, M. M., & Schaffner, W. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.15.6419 · Cited by 4,179
Semenza, G. L., & Wang, G. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5447 · Cited by 2,617
Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures.
Dawson, V. L., Dawson, T. M., London, E. D., Bredt, D. S., & Snyder, S. H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.14.6368 · Cited by 2,174
Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1.
Semenza, G., Roth, P. H., Fang, H. M., & Wang, G. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31580-6 · Cited by 1,892
Research works printed but not linked: 4
- S Moncada, R M J Palmer, E A Higgs Pharmacol Rev 43, 109–142 (1991).
- R H Wenger, M Gassmann Biol Chem 378, 609–616 (1997).
- 10.1128/mcb.12.12.5447-5454.1992 · DOI · Paper page
- C S Cobbs, J E Brenman, K D Aldape, D S Bredt, M A Israel Cancer Res 55, 727–730 (1995).
Cited by
Sorted by citations
Items 101–200 of 224
Ramanathan, M., Giladi, A., & Leibovich, S. J. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800608 · Cited by 60
Calpain Mediates a von Hippel-Lindau Protein–independent Destruction of Hypoxia-inducible Factor-1α
Zhou, J., Köhl, R., Herr, B., Frank, R., & Brüne, B. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-08-0770 · Cited by 61
“Supporting studies noticed attenuated binding of HIF-1 to the DNA under hypoxic or CoCl2 treatments in combination with NO (Liu et al., 1998; Sogawa et al., 1998; Brüne and Zhou, 2003).”
BackgroundGPER Mediates Cardiotropic Effects in Spontaneously Hypertensive Rat Hearts
Francesco, E. M. D., Angelone, T., Pasqua, T., Pupo, M., Cerra, M. C., & Maggiolini, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069322 · Cited by 58
“Noteworthy, previous studies have shown that NO is able to inhibit HIF-1 activity and expression [61–64].”
BackgroundiNOS Expression Inhibits Hypoxia-Inducible Factor-1 Activity
Yin, J., Yang, D., Ku, G., & Hsu, C. Y. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3896 · Cited by 57
Repurposing Drugs in Oncology (ReDO)—nitroglycerin as an anti-cancer agent
Sukhatme, V. V., Bouche, G., Meheus, L., Sukhatme, V. P., & Pantziarka, P. (2015) · ecancermedicalscience · doi:10.3332/ecancer.2015.568 · Cited by 56
“…Mebendazole [52] Cimetidine [53] Colorectal Microtubule disruption, AMPK/mTOR, immunomodulation, anti-histamine, COX-2 Cimetidine [36] Mebendazole [54] Metformin ( NCT01941953 ) Aspirin [55] Note that references to clinical trials or published papers are indicative of trials or case reports where…”
BackgroundInduced Nitric Oxide Synthase as a Major Player in the Oncogenic Transformation of Inflamed Tissue
Yang, G., Taboada, S., & Liao, J. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-530-9_8 · Cited by 56
Nitric Oxide Nano-Delivery Systems for Cancer Therapeutics: Advances and Challenges
Vong, L. B., & Nagasaki, Y. (2020) · Antioxidants · doi:10.3390/antiox9090791 · Cited by 55
Padula, P. H. L., & Costa, L. E. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00988.2004 · Cited by 51
Hypoxia-Inducible PIM Kinase Expression Promotes Resistance to Antiangiogenic Agents
Casillas, A. L., Toth, R. K., Sainz, A. G., Singh, N., Desai, A. A., Kraft, A. S., & Warfel, N. A. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1318 · Cited by 51
“In addition, several studies demonstrate that decreased mitochondrial oxygen consumption can elevate intracellular oxygen levels in hypoxia, which is sufficient to enhance PHD function and effectively degrade HIFa isoforms in hypoxia (50, 51).”
BackgroundEffects of nitric oxide donors on vascular endothelial growth factor gene induction
Kimura, H., Ogura, T., Kurashima, Y., Weisz, A., & Esumi, H. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02029-6 · Cited by 51
“There are some reports of an inhibitory effect of NO donors on the VEGF expression [10–12].”
BackgroundNitroreductase-activated nitric oxide (NO) prodrugs
Sharma, K., Sengupta, K., & Chakrapani, H. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.08.066 · Cited by 50
17β-Estradiol decreases hypoxic induction of erythropoietin gene expression
Mukundan, H., Resta, T. C., & Kanagy, N. L. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00573.2001 · Cited by 50
“Although several investigators have shown that NO attenuates HIF-1 activity/stability during hypoxia thereby decreasing expression of hypoxiainduced genes (57), other studies suggest that HIF-1 is stabilized in the presence of NO (28, 50, 51).”
BackgroundOligomycin inhibits HIF-1α expression in hypoxic tumor cells
Gong, Y., & Agani, F. H. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00443.2004 · Cited by 54
“Nitric oxide (NO) inhibits HIF-1 accumulation during hypoxia (2, 9, 18, 29); effects on mitochondrial complex I (2) as well as complex IV (9), have been implicated as underlying mechanisms.”
BackgroundSensory Neurons Respond to Hypoxia with NO Production Associated with Mitochondria
Henrich, M., Hoffmann‐Sommergruber, K., König, P., Gruß, M., Fischbach, T., Gödecke, A., Hempelmann, G., & Kummer, W. (2002) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2002.1111 · Cited by 47
Targeting oxidative stress, a crucial challenge in renal transplantation outcome
Carcy, R., Cougnon, M., Poët, M., Durandy, M., Sicard, A., Counillon, L., Blondeau, N., Hauet, T., Tauc, M., & Pisani, D. F. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.04.023 · Cited by 50
Zelko, I. N., & Folz, R. J. (2004) · Endocrinology · doi:10.1210/en.2004-1007 · Cited by 48
NO and transcriptional regulation: from signaling to death
Zhou, J., & Brüne, B. (2004) · Toxicology · doi:10.1016/j.tox.2004.11.021 · Cited by 47
Crosstalk between nitric oxide and hypoxia-inducible factor signaling pathways: an update
Poyton, R., & Hendrickson, M. (2015) · Research and Reports in Biochemistry · doi:10.2147/rrbc.s58280 · Cited by 45
“Although several early studies reported that NO destabilizes HIF-1α, these studies used exogenous NO donors.(63,64) This is problematic R es ea rc h an d R ep or ts in B io ch em is tr y do w nl oa de d fr om h ttp s: //w w w .”
Therapeutic Targets for Hypoxia-Elicited Pathways
Taylor, C. T., & Colgan, S. P. (1999) · Pharmaceutical Research · doi:10.1023/a:1011936016833 · Cited by 44
Site-directed delivery of nitric oxide to cancers
Sharma, K., & Chakrapani, H. (2014) · Nitric Oxide · doi:10.1016/j.niox.2014.07.005 · Cited by 44
Itoh, T., Namba, T., Fukuda, K., Semenza, G. L., & Hirota, K. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03119-2 · Cited by 43
Regulation of pleiotropic physiological roles of nitric oxide signaling
Soundararajan, L., Dharmarajan, A., & Samji, P. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110496 · Cited by 45
Zhao, Q., Du, J., Gu, H., Teng, X., Zhang, Q., Qin, H., & Liu, N. (2007) · Pancreas · doi:10.1097/01.mpa.0000250135.95144.b6 · Cited by 42
“This result confirmed that the tension of O2 is indeed a prominent factor for the accumulation and the activation of HIF-1>.”
BackgroundInfluentialWiegant, F. A. C., Malyshev, I. Y., Kleschyov, A. L., van Faassen, E. E., & Vanin, A. F. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00806-6 · Cited by 42
Martínez‐Romero, R., Martínez‐Lara, E., Aguilar‐Quesada, R., Peralta, A., Oliver, F. J., & Siles, E. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21781 · Cited by 40
“In this sense some authors have proposed that nitric oxide (NO) blocks HIF-1a stabilization [Sogawa et al., 1998; Agani et al., 2002; Hagen et al., 2003] while others contend that it causes HIF-1a accumulation [Brune and Zhou, 2003; Metzen et al., 2003b].”
BackgroundNitric oxide signalling and cellular adaptations to changes in oxygenation
Postovit, L.-M. M., Sullivan, R., Adams, M. A., & Graham, C. H. (2004) · Toxicology · doi:10.1016/j.tox.2004.11.022 · Cited by 40
Reactive Oxygen Species Drives Myocardial Angiogenesis?
Maulik, N. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.2161 · Cited by 39
Hypoxia‐Inducible Factor‐1α Under the Control of Nitric Oxide
Brüne, B., & Zhou, J. (2007) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)35024-6 · Cited by 39
Kim, J.-E., & Sheen, Y. Y. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00283-5 · Cited by 38
Zaghloul, N., Patel, H., Codipilly, C. N., Marambaud, P., Dewey, S. L., Frattini, S. A., Huerta, P. T., Nasim, M. M., Miller, E. J., & Ahmed, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108168 · Cited by 37
“NO inhibits hypoxia-inducible transcription of the Epo gene through suppression of HIF-1alpha expression, DNA binding activity, and transcriptional activity [53–54].”
BackgroundNitric Oxide and Immune Responses in Cancer: Searching for New Therapeutic Strategies
Sahebnasagh, A., Saghafi, F., Negintaji, S., Hu, T., Shabani-Borujeni, M., Safdari, M., Ghaleno, H. R., Miao, L., Qi, Y., Wang, M., et al. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210707194543 · Cited by 39
Nitric oxide produced by cytochrome c oxidase helps stabilize HIF-1α in hypoxic mammalian cells
Ball, K. A., Nelson, A. W., Foster, D. G., & Poyton, R. Ο. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.03.050 · Cited by 38
“While several early studies reported that NO destabilizes HIF-1α in hypoxic cells [15;25;33] recent studies have revealed a more complex picture in which NO levels are important.”
ResultZaobornyj, T., Valdez, L. B., Padula, P. H. L., Costa, L. E., & Boveris, A. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00986.2004 · Cited by 37
Chen, Y., Fang, L., Zhou, W., Chang, J., Zhang, X., He, C., Chen, C., Yan, R., Yan, Y., Lu, Y., et al. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00989-z · Cited by 33
“It has been reported that NO treatment can effectively inhibit the expression of HIF-1α in hypoxic tumor cells [24].”
BackgroundMagnesium Deficiency Causes Loss of Response to Intermittent Hypoxia in Paraganglion Cells
Torii, S., Kobayashi, K., Takahashi, M., Katahira, K., Goryo, K., Matsushita, N., Yasumoto, K., Fujii‐Kuriyama, Y., & Sogawa, K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.004424 · Cited by 33
Self-citationNO‐Mediated Chemoresistance in C6 Glioma Cells
Yang, D., Yin, J., Mishra, S., MISHRA, R., & Hsu, C. Y. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04052.x · Cited by 32
Hypoxia-inducible factors: Crosstalk between their protein stability and protein degradation
Wei, W., & Yu, X. D. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.08.009 · Cited by 33
Corti, A., Franzini, M., Scataglini, I., & Alfonso Pompella, C. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.08.002 · Cited by 33
Hypoxia-induced pulmonary endothelin-1 expression is unaltered by nitric oxide
Earley, S., Nelin, L. D., Chicoine, L. G., & Walker, B. R. (2002) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00829.2001 · Cited by 30
NG-monomethyl-l-arginine inhibits erythropoietin gene expression by stimulating GATA-2
Tarumoto, T., Imagawa, S., Ohmine, K., Nagai, T., Higuchi, M., Imai, N., Suzuki, N., Yamamoto, M. P., & Ozawa, K. (2000) · Blood · doi:10.1182/blood.v96.5.1716 · Cited by 30
Takabuchi, S., Hirota, K., Nishi, K., Oda, S., Oda, T., Shingu, K., Takabayashi, A., Adachi, T., Semenza, G. L., & Fukuda, K. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.064 · Cited by 30
Ortiz‐Masiá, D., Hernández, C., Quintana, E., Veiázquez, M., Cebrián, S., Riaño, A., Calatayud, S., Esplugues, J. V., & Barrachina, M. D. (2009) · The FASEB Journal · doi:10.1096/fj.09-137489 · Cited by 28
Hypoxia inducible factor-1: regulation by nitric oxide in posthypoxic microvascular endothelium
Natarajan, R., Jones, D. G., Fisher, B. J., Wallace, T. J., Ghosh, S., & Fowler, A. A. (2005) · Biochemistry and Cell Biology · doi:10.1139/o05-047 · Cited by 28
Kaluz, Š., Kaluzová, M., & Stanbridge, E. J. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21644 · Cited by 27
“Use of NO donors can activate the HIF system under normoxia, but the same compounds may inhibit HIF under hypoxia [Sogawa et al., 1998].”
BackgroundBeltrán-Povea, A. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i3.605 · Cited by 27
Igwe, E. I., Essler, S., Al-Furoukh, N., Dehne, N., & Brüne, B. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-408 · Cited by 27
“Nitric oxide donors (DETA-NO, GSNO) decrease hypoxia-elicited HIF-1α stabilization and HIF-1 transcriptional activation [17-19].”
BackgroundIshii, K., Takayanagi, A., Shimizu, S., Abe, H., Sogawa, K., & Kobayashi, N. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.12.017 · Cited by 27
Self-citationCattaneo, M. G., Cappellini, E., Benfante, R., Ragni, M., Omodeo‐Salè, F., Nisoli, E., Borgese, N., & Vicentini, L. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029680 · Cited by 26
Mechanisms of hypoxic signal transduction regulated by reactive nitrogen species
Sumbayev, V. V., & Yasinska, I. M. (2007) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2007.01919.x · Cited by 27
Cyclic AMP Represses the Hypoxic Induction of Hypoxia-inducible Factors in PC12 Cells
Torii, S., Okamura, N., Suzuki, Y., Ishizawa, T., Yasumoto, K., & Sogawa, K. (2009) · The Journal of Biochemistry · doi:10.1093/jb/mvp129 · Cited by 25
Self-citationHypoxia-Inducible Factor Stabilizers: a New Avenue for Reducing BP While Helping Hemoglobin?
Yousaf, F., & Spinowitz, B. (2016) · Current Hypertension Reports · doi:10.1007/s11906-016-0629-6 · Cited by 23
Inhibitory effects of nitric oxide on invasion of human cancer cells
Wang, F., Zhang, R., Xia, T., Hsu, E. L., Cai, Y., Gu, Z., & Hankinson, O. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.08.001 · Cited by 23
“In this regard, it is of interest that NO generated from various NO-donors has been shown to inhibit the expression of HIF-1α, via activating the prolyl hydroxylase-domain proteins [9,10].”
BackgroundMiki, K., Unno, N., Nagata, T., Uchijima, M., Konno, H., Koide, Y., & Nakamura, S. (2004) · Shock · doi:10.1097/01.shk.0000140664.80530.bd · Cited by 22
Nitric Oxide Donors Inhibit Luciferase Expression in a Promoter-independent Fashion
Fan, X., Roy, E., Zhu, L., Murphy, T. C., Kozlowski, M., Nanes, M. S., & Rubin, J. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209911200 · Cited by 22
The metal-nonoate Ni(SalPipNONO) inhibitsin vitrotumor growth, invasiveness and angiogenesis
Ciccone, V., Monti, M., Monzani, E., Casella, L., & Morbidelli, L. (2018) · Oncotarget · doi:10.18632/oncotarget.24350 · Cited by 21
Wang, S., Qian, Y., Gong, D., Zhang, Y., & Fan, Y. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.08.029 · Cited by 20
HIF-1-Dependent VEGF Reporter Gene Assay by a Stable Transformant of CHO Cells.
Yamazaki, Y. M., Egawa, K., Nose, K., Kunimoto, S., & TAKEUCHI, T. (2003) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.26.417 · Cited by 20
Díez, I., Calatayud, S., Hernández, C., Quintana, E., O'Connor, J., Esplugues, J. V., & Barrachina, M. D. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00654.x · Cited by 19
“…2001) In recent years, modulation by NO of the activity of the transcription factor hypoxia inducible factor-1 (HIF-1) has been reported in cultured cells (Sogawa et al., 1998; Kimura et al., 2000; Yin et al., 2000; Sandau et al., 2001; Agani et al., 2002; Hagen et al., 2003; Mateo et al., 2003).”
BackgroundRiaño, A., Ortiz‐Masiá, D., Velázquez, M., Calatayud, S., Esplugues, J. V., & Barrachina, M. D. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-011-0374-1 · Cited by 19
Inhibitory effect of extracellular histidine on cobalt-induced HIF-1α expression
Torii, S., Kurihara, A., Li, X. Y., Yasumoto, K., & Sogawa, K. (2010) · The Journal of Biochemistry · doi:10.1093/jb/mvq129 · Cited by 19
Self-citationGoryo, K., Torii, S., Yasumoto, K., & Sogawa, K. (2011) · The Journal of Biochemistry · doi:10.1093/jb/mvr061 · Cited by 18
Self-citationReduced Retinal Degeneration in an Oxidative Stress Organ Culture Model through an iNOS-Inhibitor
Mueller‐Buehl, A. M., Tsai, T., Hurst, J., Theiß, C., Peters, L., Hofmann, L., Herms, F., Kuehn, S., Schnichels, S., & Joachim, S. C. (2021) · Biology · doi:10.3390/biology10050383 · Cited by 18
“It is known that hypoxic and oxidative stress can reinforce each other and the modulation of HIF-1 by NO has already been reported in various models of cultured cells [51,52].”
BackgroundEndogenous nitric oxide attenuates erythropoietin gene expression in vivo
Todorov, V., Gess, B., Gödecke, A., Wagner, C., Schrader, J., & Kurtz, A. (2000) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004249900192 · Cited by 18
Lukyanova, L. D., Sukoyan, G. V., & Kirova, Y. I. (2013) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-013-2008-5 · Cited by 18
Sumbayev, V. V., & Yasinska, I. M. (2006) · Free Radical Research · doi:10.1080/10715760600649648 · Cited by 18
Leary, S. C., & Moyes, C. D. (2000) · Cell and molecular responses to stress · doi:10.1016/s1568-1254(00)80017-0 · Cited by 17
L-arginine rescues decreased erythropoietin gene expression by stimulating GATA-2With L-NMMA
Imagawa, S., Tarumoto, T., Suzuki, N., Mukai, H. Y., Hasegawa, Y., Higuchi, M., Neichi, T., Ozawa, K., Yamamoto, M. P., & Nagasawa, T. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00152.x · Cited by 15
Essential factors associated with hepatic angiogenesis
Das, S. K., & Vasudevan, D. M. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.09.027 · Cited by 15
Moonlighting by PPE2 Protein: Focus on Mycobacterial Virulence
Pal, R. K., Ghosh, S., & Mukhopadhyay, S. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100212 · Cited by 14
Olson, N. C., Kasahara, D. I., Hristova, M., Bernstein, R., Janssen-Heininger, Y. M. W., & van der Vliet, A. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0035oc · Cited by 14
17-β Estradiol Independently Regulates Erythropoietin Synthesis and NOS Activity during Hypoxia
Mukundan, H., Resta, T. C., & Kanagy, N. L. (2004) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200402000-00023 · Cited by 13
“Sogawa and others have shown that NO donors attenuate both HIF-1 activity and EPO expression in hypoxic Hep3B cells.(9,10) It is therefore possible that increased NO bio-availability in vivo mediates E2- attenuation of EPO synthesis.”
BackgroundHayashida, Y., Kondo, H., & González, C. (2006) · Advances in experimental medicine and biology · doi:10.1007/0-387-31311-7 · Cited by 13
Hussien, N. I., & Emam, H. T. (2015) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2015.12.001 · Cited by 12
“NO attenuates HIF-1 activity/stability during hypoxia thereby decreasing expression of hypoxia induced genes.(60) Another mechanism explained by Bishop et al.”
BackgroundShi, Q., Liu, X. B., Wang, N., Zheng, X., Fu, J., & Zheng, J. (2016) · PubMed Central · Cited by 12
Morbidelli, L., Donnini, S., & Ziche, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816545-4.00004-9 · Cited by 12
Dual Influence of Nitric Oxide on Gene Regulation During Hyoixua
Adhikary, G., Premkumar, D. R., & Prabhakar, N. R. (2002) · Advances in experimental medicine and biology · doi:10.1007/0-306-46825-5_27 · Cited by 12
Erythropoietin induction in Hep3B cells is not affected by inhibition of heme biosynthesis
Horiguchi, H., & Bunn, H. F. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(99)00169-x · Cited by 10
Therapeutic Application of Nitric Oxide in Human Diseases
Namkoong, S., & Kim, Y. (2010) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2010.18.4.351 · Cited by 9
“…reported that NO mediates the suppression of hypoxia-induced production of VEGF in smooth muscle cells by decreasing HIF-1α DNA binding activity (Sogawa et al., 1998; Huang et al., 1999), whereas others have shown enhanced HIF-1 binding activity in response to NO in human glioblastoma and rat…”
BackgroundHypoxia-related gene expression in porcine skeletal muscle tissues at different altitude
Zhang, J., Chen, L., Long, K., & Mu, Z. P. (2015) · Genetics and Molecular Research · doi:10.4238/2015.september.28.10 · Cited by 9
“As a master regulator of the cellular response to hypoxia, HIF1A triggers the widespread transcription of genes involved in numerous physiological processes (Sogawa et al., 1998; Yee Koh et al., 2008).”
BackgroundNitric Oxide in Gentamicin-induced Acute Tubular Necrosis in Rats
Nakaš-Ićindić, E., Avdagić, N., Mijanović, M., Prašović, S., Začiragić, A., Začiragić, A., & Tahirović, G. (2005) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2005.3288 · Cited by 9
Tuncer, M. C., Hatipoğlu, E. S., Öztürk, H., Kervancıoğlu, P., & Büyükbayram, H. (2005) · European Surgical Research · doi:10.1159/000090331 · Cited by 9
“There are several reports demonstrating that exposure of cells to certain nitric oxide (NO) donors or gaseous NO modulates HIF-1 activity [ ,”
BackgroundEdaravone, a free radical scavenger, accelerates wound healing in diabetic mice.
Naito, R., Nishinakamura, H., Watanabe, T., NAKAYAMA, J., & Kodama, S. (2014) · PubMed · Cited by 9
Tsuruda, T., Hatakeyama, K., Masuyama, H., Sekita, Y., Imamura, T., Asada, Y., & Kitamura, K. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00503.2009 · Cited by 8
“However, the nitric oxide signaling pathway has been shown to inhibit the HIF-1 DNAbinding activity and transcriptional activity of HIF-1 target genes in hypoxic cells (11, 20, 32).”
BackgroundKim, J., Barsoum, I. B., Loh, H. A., Paré, J., Siemens, D. R., & Graham, C. H. (2020) · Bioscience Reports · doi:10.1042/bsr20192345 · Cited by 8
Pugh, C. W. (2003) · Annals of Medicine · doi:10.1080/07853890310017062 · Cited by 8
Bonavida, B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-811020-1.00002-8 · Cited by 7
Huwiler, A., & Pfeilschifter, J. M. (2006) · Biological Chemistry · doi:10.1515/bc.2006.165 · Cited by 8
“Whereas it induces HIF-1a expression under normoxic conditions, it reduces HIF-1a expression under hypoxic conditions (Sogawa et al., 1998).”
BackgroundStemness of Human Pluripotent Cells: Hypoxia-Like Response Induced by Low Nitric Oxide
Caballano‐Infantes, E., Díaz, I., Hitos, A. B., Cahuana, G. M., Martı́nez-Ruiz, A., Soria-Juan, B., Rodríguez-Griñolo, R., Hmadcha, A., Martı́n, F., Soria, B., et al. (2021) · Antioxidants · doi:10.3390/antiox10091408 · Cited by 6
La régulation de HIF-1α (Hypoxia-Inducible Factor-1α) : un air nouveau dans le domaine de l’hypoxie
Berta, M., Brahimi‐Horn, C., & Pouysségur, J. (2004) · Journal de la Société de Biologie · doi:10.1051/jbio/2004198020113 · Cited by 8
Avdagić, N., Nakaš-Ićindić, E., Rašić, S., Hadžović-Džuvo, A., Začiragić, A., & Valjevac, A. (2007) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2007.3025 · Cited by 5
NADPH Oxidase 4: Crucial for Endothelial Function under Hypoxia—Complementing Prostacyclin
Brendel, H., Mittag, J., Hofmann, A., Hempel, H., Giebe, S., Diaba‐Nuhoho, P., Wolk, S., Reeps, C., Morawietz, H., & Brunßen, C. (2024) · Antioxidants · doi:10.3390/antiox13101178 · Cited by 9
“It has been reported that long-term exposure to nitric oxide, comparable to our experimental conditions, under flow has reducing effects on HIF1a accumulation and activity [40–42].”
Cancer cachexia has many symptoms but only one cause: anoxia
Koltai, T. (2020) · F1000Research · doi:10.12688/f1000research.22624.1 · Cited by 3
Effects of Glutathione Depletion on Hypoxia-induced Erythropoietin Production in Rats
Ando, D., Yamakita, M., Yamagata, Z., & Koyama, K. (2009) · Journal of PHYSIOLOGICAL ANTHROPOLOGY · doi:10.2114/jpa2.28.211 · Cited by 3
Hypoxic Signal Transduction and Compensatory Mechanisms in the Neurovascular Unit
Ma, X., Zou, Z., & Shi, Q. (2024) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2308149 · Cited by 2
Therapeutic Strategies that Target the HIF System
Cook, K. M., & Schofield, C. J. (2008) · Springer eBooks · doi:10.1007/978-0-387-71518-6_32 · Cited by 2
Mechanisms and triggers of adaptation to hypoxia
Владимирович, Л. А., Cherkashin, D. V., Валерьевич, Е. С., Alanichev, A. E., Ivanov, V. S., & Кутелев, Г. Г. (2021) · Reviews on Clinical Pharmacology and Drug Therapy · doi:10.17816/rcf193269-280 · Cited by 2
Role of Nitric Oxide for Modulation of Cancer Therapy Resistance
Efferth, T. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1432-3_14 · Cited by 2
Oxygen- or Redox-Dependent Regulation
Fandrey, J. (2003) · CRC Press eBooks · doi:10.1201/b14819-6 · Cited by 1
Molecular Mechanisms of Hypoxia-Regulated Angiogenesis
Łoboda, A., Józkowicz, A., & Dulak, J. (2013) · Springer eBooks · doi:10.1007/978-3-7091-1428-5_8 · Cited by 1
Postovit, L.-M. M. (2015) · Springer eBooks · doi:10.1007/978-3-319-13611-0_5 · Cited by 1
Metadata
- Authors
- Sogawa, K., Numayama-Tsuruta, K., Ema, M., Abe, M., Abe, H., & Fujii-Kuriyama, Y.
- Affiliations
- Tohoku University (JP)
- Department of Chemistry, Graduate School of Science, Tohoku University, Aoba-ku, Sendai 980-77, Japan
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1998-06-23
- Volume
- 95
- Issue
- 13
- Pages
- 7368-7373
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC22620
- OpenAlex
- W2046905314
- Cited by
- 224
- References
- 51
- Citations by year
- 2026: 1 · 2024: 2 · 2022: 3 · 2021: 11 · 2020: 3 · 2019: 3 · 2018: 3 · 2017: 3 · 2016: 3 · 2015: 8 · 2014: 8 · 2013: 8 · 2012: 3
- FWCI
- 4.06
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Keywords
- HIF-1, nitric oxide donors, hypoxia, erythropoietin, aldolase A, vascular endothelial growth factor, hypoxia response element, sodium nitroprusside, SIN-1, transcriptional regulation
- MeSH terms
- Cells, Cultured, DNA, DNA-Binding Proteins, Enzyme Induction, Erythropoietin, Fructose-Bisphosphate Aldolase, Humans, Nitric Oxide, Nitroprusside, Nuclear Proteins, RNA, Messenger, Transcription Factors, Transcription, Genetic, Transfection, Cell Hypoxia, Helix-Loop-Helix Motifs, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review